医学
骨传导
助听器
交叉研究
听力损失
噪音(视频)
感音神经性聋
听力学
病理
人工智能
替代医学
计算机科学
安慰剂
图像(数学)
作者
Ken Takaki,Akinori Kashio,Etsushi Nozaki,Tomomi Kanai,Teru Kamogashira,Fumikazu Saze,Tsukasa Uranaka,Shinji Urata,Hajime Koyama,Yoshihiro Kawahara,Tatsuya Yamasoba
标识
DOI:10.1097/mao.0000000000004199
摘要
Objective To investigate if cartilage conduction (CC) rerouting devices are noninferior to air-conduction (AC) rerouting devices for single-sided deafness (SSD) patients by measuring objective and subjective performance using speech-in-noise tests that resemble a realistic hearing environment, sound localization tests, and standardized questionnaires. Study Design Prospective, single-subject randomized, crossover study. Setting Anechoic room inside a university. Patients Nine adults between 21 and 58 years of age with severe or profound unilateral sensorineural hearing loss. Interventions Patients’ baseline hearing was assessed; they then used both the cartilage conduction contralateral routing of signals device (CC-CROS) and an air-conduction CROS hearing aid (AC-CROS). Patients wore each device for 2 weeks in a randomly assigned order. Main Outcome Measures Three main outcome measures were 1) speech-in-noise tests, measuring speech reception thresholds; 2) proportion of correct sound localization responses; and 3) scores on the questionnaires, “Abbreviated Profile of Hearing Aid Benefit” (APHAB) and “Speech, Spatial, and Qualities of Hearing Scale” with 12 questions (SSQ-12). Results Speech reception threshold improved significantly when noise was ambient, and speech was presented from the front or the poor-ear side with both CC-CROS and AC-CROS. When speech was delivered from the better-ear side, AC-CROS significantly improved performance, whereas CC-CROS had no significant effect. Both devices mainly worsened sound localization, whereas the APHAB and SSQ-12 scores showed benefits. Conclusion CC-CROS has noninferior hearing-in-noise performance except when the speech was presented to the better ear under ambient noise. Subjective measures showed that the patients realized the effectiveness of both devices.
科研通智能强力驱动
Strongly Powered by AbleSci AI